Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 10, 2025 09:54 ET | Source: Research and Markets

68 Plaque Psoriasis (Country) Market Analysis and Sales Forecast to 2030

Dublin, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The "Plaque Psoriasis: 68-Market Analysis and Sales Forecast - Update (2025)" report has been added to ResearchAndMarkets.com's offering. This report...
September 04, 2025 04:01 ET | Source: Research and Markets

Celiac Diseases Drugs Market Analysis Report 2025-2029 | Inorganic Growth Strategies Propel Expansion

Dublin, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The "Celiac Diseases Drugs Market 2025-2029" has been added to ResearchAndMarkets.com's offering. The celiac diseases drugs market is set for...
July 21, 2025 04:13 ET | Source: Research and Markets

Immunology Collaboration and Licensing Agreements Analysis Report 2016-2025 | Efficiently Identify Immunology Deal Structures and Terms - Upfront, Milestone, Royalties

Dublin, July 21, 2025 (GLOBE NEWSWIRE) -- The "Immunology Collaboration and Licensing Deals 2016-2025" report has been added to ResearchAndMarkets.com's offering. Fully revised and updated, the...
July 14, 2025 09:00 ET | Source: Research and Markets

HER2+ Gastric Cancer Market Analysis and Forecast Report 2025-2035: AstraZeneca, Merck, and Roche Lead Innovation in HER2+ Gastric Cancer Therapies

Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The "HER2+ Gastric Cancer Market - A Global and Regional Analysis: Focus on Regional Analysis - Analysis and Forecast, 2025-2035" report has been added to ...
June 12, 2025 05:26 ET | Source: Research and Markets

Autoimmune Collaboration and Licensing Deals Report 2025: Comprehensive Analysis of 943 Autoimmune Licensing Deals (2016-2025) Across 30+ Diseases

Dublin, June 12, 2025 (GLOBE NEWSWIRE) -- The "Autoimmune Collaboration and Licensing Deals 2016-2025" report has been added to ResearchAndMarkets.com's offering.Autoimmune Collaboration and...
June 12, 2025 01:00 ET | Source: Rose Piquante Consulting

AstriVax Therapeutics Further Strengthens Team with the Appointment of Dieter Weinand as New Chair of the Board of Directors

US-based Dieter Weinand is the former CEO of Bayer Pharma with more than 25 years of experience as a senior business leader in the pharmaceutical industryThe appointment comes as AstriVax Therapeutics...
June 05, 2025 01:00 ET | Source: Astrivax

AstriVax Therapeutics Initiates Clinical Development of AVX70371, a Hepatitis B immunotherapy using Launch-iT technology

Third asset to advance into clinical trials, validating broad potential of Launch-iT platformAll subjects treated with first dose of AVX70371 Launch-iT, as part of multiple dosing schedule Potential...
June 04, 2025 11:02 ET | Source: Research and Markets

Peanut Allergy Treatment Market Trends, Opportunities, and Forecast, 2020-2024 & 2025-2030: Advances in Targeted Therapies like Immunotherapy Fuel growth Despite High Treatment Costs

Dublin, June 04, 2025 (GLOBE NEWSWIRE) -- The "Peanut Allergy Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to ...
May 08, 2025 05:16 ET | Source: Research and Markets

Histone Deacetylase (HDAC) 6 Pipeline Landscape 2025: In-Depth Insights Into Over 20 Companies and 26 Drugs Within the HDAC 6 Inhibitors Pipeline

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Histone Deacetylase 6 - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering. This report offers a detailed analysis...
March 20, 2025 08:14 ET | Source: Research and Markets

Interleukin-2 Market Size, Target Population, Competitive Landscape & Market Forecast to 2034: Japan Leads Interleukin-2 Market Growth, With NSCLC & Atopic Dermatitis Driving Demand

Dublin, March 20, 2025 (GLOBE NEWSWIRE) -- The "Interleukin-2 - Market Size, Target Population, Competitive Landscape & Market Forecast - 2034" report has been added to ResearchAndMarkets.com's...